Pure Global

Total Bilirubin at the Bedside Measurement System - Vietnam Registration 240000645/PCBB-HCM

Access comprehensive regulatory information for Total Bilirubin at the Bedside Measurement System in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000645/PCBB-HCM and manufactured by Bilimetrix S.r.l.,. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ Y TẾ DMED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240000645/PCBB-HCM
Registration Details
Vietnam MOH Registration: 240000645/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Total Bilirubin at the Bedside Measurement System
VN: Hệ thống đo bilirubin toàn phần tại giường
Hệ thống đo bilirubin toàn phần tại giường
Risk Class TTBYT Loại B

Registration Details

240000645/PCBB-HCM

000.00.19.H29-240320-0008

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Bilimetrix S.r.l.,

Technical Details

Bilistick® is a point-of-care diagnostic instrument for the determination of total serum bilirubin (TSB) concentration in the blood of newborns. The determination of TSB concentration using the Bilistick® system does not require the use of reagents, thus simplifying the measurement process. After the sample is loaded, the concentration of bilirubin is calculated and displayed within a few minutes. The Bilistick® system allows for the determination of bilirubin concentration in the range from 1 mg/dL to 40 mg/dL (17 to 684 µmol/L) with accuracy comparable to that of traditional clinical laboratory instruments.

Dates and Status

Mar 27, 2024